KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Short term Debt (2016 - 2025)

Cvs Health (CVS) has disclosed Short term Debt for 17 consecutive years, with $1.2 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 74.6% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Sep 2025, down 74.6%, and an annual FY2024 reading of $3.6 billion, up 30.74% over the prior year.
  • Short term Debt was $1.2 billion for Q3 2025 at Cvs Health, down from $6.2 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $6.2 billion in Q2 2025 and bottomed at $60.0 million in Q2 2021.
  • Average Short term Debt over 5 years is $2.7 billion, with a median of $2.3 billion recorded in 2021.
  • The sharpest move saw Short term Debt crashed 99.27% in 2021, then skyrocketed 6598.33% in 2022.
  • Year by year, Short term Debt stood at $4.2 billion in 2021, then plummeted by 57.72% to $1.8 billion in 2022, then surged by 55.91% to $2.8 billion in 2023, then surged by 30.74% to $3.6 billion in 2024, then tumbled by 65.59% to $1.2 billion in 2025.
  • Business Quant data shows Short term Debt for CVS at $1.2 billion in Q3 2025, $6.2 billion in Q2 2025, and $1.3 billion in Q1 2025.